BLM p.P868L has been characterized as an allele that is unlikely to cause BS, but causes partial loss of function manifested by an intermediate sensitivity to hydroxyurea [54], and has been associated with increased rectal cancer risk [55]. Here, BLM is linked to rectal cancer.